Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux

Angie M. Torres-Adorno, Heidi Vitrac, Yuan Qi, Lin Tan, Kandice R. Levental, Yang Yi Fan, Peiying Yang, Robert S. Chapkin, Bedrich L. Eckhardt, Naoto T. Ueno

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux'. Together they form a unique fingerprint.

Medicine & Life Sciences